Header Logo

Connection

JOHN KIRKWOOD to Receptor, EphA2

Back to Details
This is a "connection" page, showing publications JOHN KIRKWOOD has written about Receptor, EphA2.
JOHN KIRKWOOD
Connection Strength
0.120
Receptor, EphA2
  1. Ligand-independent EPHA2 signaling drives the adoption of a targeted therapy-mediated metastatic melanoma phenotype. Cancer Discov. 2015 Mar; 5(3):264-73.
    View in: PubMed
    Score: 0.120
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.